Adam Todd1, Jaafar Al-Khafaji2, Nasima Akhter3, Adetayo Kasim3, Rachel Quibell4, Kelly Merriman5, Holly M Holmes6. 1. School of Pharmacy, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. 2. Department of Internal Medicine, University of Nevada, Reno School of Medicine, Reno, NV, USA. 3. Wolfson Research Institute for Health and Wellbeing, Durham University, Durham, UK. 4. Department of Palliative Medicine, Royal Victoria Infirmary, Newcastle upon Tyne, UK. 5. University of Texas MD Anderson Cancer Center, Houston, TX, USA. 6. Division of Geriatric and Palliative Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Abstract
AIMS: The aims of the current study were: (i) to examine the prescribing of preventative medication in a cohort of people with advanced lung cancer on hospital admission and discharge across different healthcare systems; and (ii) to explore the factors that influence preventative medication prescribing at hospital discharge. METHODS: A retrospective cohort study was conducted across two centres in the UK and the US. The prescribing of preventative medication was examined at hospital admission and discharge for patients who died of lung cancer. A zero-inflated negative binomial regression model was used to examine the association between preventative medications at discharge and patient- and hospital-based factors. The classes of preventative medication prescribed included were: vitamins and minerals, and antidiabetic, antihypertensive, antihyperlipidaemic and antiplatelet medications. RESULTS: In the UK site (n = 125), the mean number of preventative medications prescribed was 1.9 [standard deviation (SD) 1.7) on admission, and 1.7 (SD 1.7) on discharge, and in the US site (n = 191) the mean was 2.6 (SD 2.2) on admission and 1.9 (SD 2.2) on discharge. The model found a significant association between the number of preventative drugs prescribed on admission and the number on discharge; it also found a significant association between the total number of drugs prescribed on discharge and the number of preventative medications on discharge. Other indicators related to patient and hospital factors were not significantly associated with the number of preventative medications supplied on discharge. CONCLUSIONS: The use of preventative medication was common in lung cancer patients, despite undergoing discharge. Patient- and hospital-based factors did not influence the prescribing of preventative medication.
AIMS: The aims of the current study were: (i) to examine the prescribing of preventative medication in a cohort of people with advanced lung cancer on hospital admission and discharge across different healthcare systems; and (ii) to explore the factors that influence preventative medication prescribing at hospital discharge. METHODS: A retrospective cohort study was conducted across two centres in the UK and the US. The prescribing of preventative medication was examined at hospital admission and discharge for patients who died of lung cancer. A zero-inflated negative binomial regression model was used to examine the association between preventative medications at discharge and patient- and hospital-based factors. The classes of preventative medication prescribed included were: vitamins and minerals, and antidiabetic, antihypertensive, antihyperlipidaemic and antiplatelet medications. RESULTS: In the UK site (n = 125), the mean number of preventative medications prescribed was 1.9 [standard deviation (SD) 1.7) on admission, and 1.7 (SD 1.7) on discharge, and in the US site (n = 191) the mean was 2.6 (SD 2.2) on admission and 1.9 (SD 2.2) on discharge. The model found a significant association between the number of preventative drugs prescribed on admission and the number on discharge; it also found a significant association between the total number of drugs prescribed on discharge and the number of preventative medications on discharge. Other indicators related to patient and hospital factors were not significantly associated with the number of preventative medications supplied on discharge. CONCLUSIONS: The use of preventative medication was common in lung cancerpatients, despite undergoing discharge. Patient- and hospital-based factors did not influence the prescribing of preventative medication.
Authors: David C Currow; James P Stevenson; Amy P Abernethy; John Plummer; Tania M Shelby-James Journal: J Am Geriatr Soc Date: 2007-04 Impact factor: 5.562
Authors: Elizabeth A Bayliss; Michael R Bronsert; Liza M Reifler; Jennifer L Ellis; John F Steiner; Deanna B McQuillen; Diane L Fairclough Journal: J Palliat Med Date: 2013-01-10 Impact factor: 2.947
Authors: Amy T Page; Rhonda M Clifford; Kathleen Potter; Darren Schwartz; Christopher D Etherton-Beer Journal: Br J Clin Pharmacol Date: 2016-06-13 Impact factor: 4.335